ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 24

Plasma Cells In Acute Systemic Lupus Erythematosus Flares Are Characterized By a Highly Diversified Repertoire Accentuated By Clonal Expansions Of VH4-34 Antibodies

Christopher Tipton1, Christopher Fucile2, Alex Rosenberg2, Scott Jenks3, Jennifer Hom4, F. Eun-Hyung Lee4 and Inaki Sanz1, 1Medicine/Rheumatology, Emory University, Atlanta, GA, 2University of Rochester, Rochester, NY, 3Allergy, Immunology, and Rheumatology, Emory University School of Medicine, Atlanta, GA, 4Emory University, Atlanta, GA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, Lupus, plasma cells and systemic lupus erythematosus (SLE), Plasmablasts

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Function and Targeting in Systemic Lupus Erythematosus

Session Type: Abstract Submissions (ACR)

Background/Purpose :

Systemic Lupus Erythematosus (SLE) is an autoimmune disease in which faulty B cell tolerance promotes the generation of multiple autoantibodies of which anti-ds DNA, anti-Sm and VH4-34-encoded 9G4 antibodies, are highly specific for this disease.   Acute SLE flares are typically accompanied by a substantial expansion of circulating antibody-secreting plasmablasts (PB) and plasma cells (PC).   Similar expansions of PB/PC populations in healthy subjects post-immunization are comprised of large clonal expansions of antigen-specific cells derived from pre-existing memory cells. To determine if SLE PB/PC expansions follow the same model, and to understand the diversity, origin and antigenic specificity of SLE PB/PC expansions, we used immunoglobulin heavy chain (IGH) deep sequencing to analyze sorted cells obtained from patients experiencing acute flares. 

Methods:

Peripheral blood lymphocytes were sorted into various B cell populations. Multiple VH family-specific primer sets were used to amplify the IGH gene from extracted RNA and then sequenced using the Illumina MiSeq platform. Sequences were analyzed using internally designed analysis software. Our software conducts quality filtering, detailed mutational analysis and identifies inter-population relationships between samples.

Results:

PB/PC expansions in SLE acute flares are a highly diversified repertoire with lower VH mutation rates than memory cells. However, within this diverse pool significant clonal expansions accounting for 0.5% or more of the entire repertoire were regularly detected.   Strikingly, VH4-34 sequences comprised the largest clones in all SLE samples.  Also of interest, a substantial fraction of PB/PC in SLE were highly evolutionarily related to a pool of activated naïve precursors.  This was in stark contrast to results obtained in PB/PC samples from healthy, vaccinated subjects, which contained large, clonal expansions, high VH mutation rates, were largely related to memory cells, and had an absence of autoreactive VH4-34 clonal expansions. Figure 1 shows clonal relationships between the top 20% of PB and PC sequences and Naive and Memory clones. Clones are arranged in increasing size from center to outer edge, and lines link matching clones.

Conclusion:

Combined, our data support a model of generalized naïve and memory activation underlying the activation phase of human SLE.  This polyclonal activation is accentuated, and possibly promotes, antigen-selected clonal expansions dominated by VH4-34-encoded autoreactive 9G4 antibodies.   Ongoing monoclonal antibody studies will clarify the nature of the selecting antigens.

OSX108_2013_05:Users:cmtipto:Desktop:Tipton_ACR_Abstract_Figure_Final.jpg


Disclosure:

C. Tipton,
None;

C. Fucile,
None;

A. Rosenberg,
None;

S. Jenks,
None;

J. Hom,
None;

F. E. H. Lee,
None;

I. Sanz,

Pfizer Inc,

5,

Biogen Idec,

9.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/plasma-cells-in-acute-systemic-lupus-erythematosus-flares-are-characterized-by-a-highly-diversified-repertoire-accentuated-by-clonal-expansions-of-vh4-34-antibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology